Search

MSK researchers continued to make strides against cancer in 2024. Learn about some of their top discoveries.

… Tuesday, December 17, 2024 Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2024. Laboratory research teams across the institution worked to advance the global understanding of cancer and to develop new therapies, while also making fundamental insights

Memorial Sloan Kettering Cancer Center recently published two retrospective studies with practice-changing insights for improving the treatment and surveillance of patients with oropharyngeal cancer.

… Friday, December 19, 2025 Teams of head and neck radiation oncologists, surgical oncologists and medical oncologists at Memorial Sloan Kettering Cancer Center (MSK) recently published two retrospective studies with practice-changing insights for improving the treatment and surveillance of patients with

Signet ring cell cancer (SRCC) was detected in the vast majority of patients with CDH1 mutations following total gastrectomy.

… Monday, July 11, 2022 Signet ring cell cancer (SRCC) was detected in the vast majority of patients with CDH1 mutations following total gastrectomy, according to a study Memorial Sloan Kettering Cancer Center (MSK) physicians published in JAMA Surgery .  (1) With the increasing availability of genomic

Learn about how MSK staff members recently participated in the 2021 Forbes China Healthcare Summit and spoke about how the war on cancer must be fought internationally with teams collaborating across political boundaries.

… Thursday, September 23, 2021 No one doctor, institution, or country can cure cancer on their own. The war on cancer must be fought internationally with teams collaborating across political boundaries. That was the key message of the 2021 Forbes China Healthcare Summit, which brought together leaders

Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation.

… Monday, May 13, 2019 Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation, according to the results of our study

MSK surgeon James Eastham explains the pros and cons of PSA testing and weighs in on a new US Preventive Services Task Force guideline.

… Tuesday, April 11, 2017 Summary An MSK expert comments on a new US Preventive Services Task Force (USPSTF) guideline regarding a type of prostate cancer screening. The USPSTF has issued an updated guideline for prostate-specific-antigen-based screening for prostate cancer. The new guideline states that

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.

… Thursday, February 27, 2014 Summary Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there. Metastasis , the process that allows some cancer cells to break off

Learn how experts at MSK who helped develop CAR T cell therapy to fight cancer are making the treatment stronger, safer, more durable and accessible to more people.

… Tuesday, November 7, 2023 Giving one dose of a treatment that will stay in a patient’s body to help it continue to fight cancer may seem like mission impossible. But it’s not. This type of immunotherapy , called CAR T cell therapy , is one of the most exciting fields in cancer treatment today. What Are

Dinshaw J. Patel, a Member in Sloan Kettering Institute's Structural Biology Program and incumbent of the Abby Rockefeller Mauzé Chair in Experimental Therapeutics, was elected to the National Academy of Sciences at its 146th annual meeting in April.

… Wednesday, July 1, 2009 Summary Dinshaw J. Patel, a Member in Sloan Kettering Institute’s Structural Biology Program and incumbent of the Abby Rockefeller Mauzé Chair in Experimental Therapeutics, was elected to the National Academy of Sciences at its 146th annual meeting in April. Dinshaw J. Patel ,

MSK researchers discover a possible reason why people with kidney cancer respond better to treatments such as immunotherapy if they are obese.

… Friday, December 20, 2019 Summary Obesity increases the risk of developing kidney cancer . However, obese people seem to do better after treatment compared with people of normal weight. MSK researchers have discovered that fat surrounding kidney tumors may play a key role in the effectiveness of kidney